schizandrin a has been researched along with Disease Models, Animal in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 3 (42.86) | 2.80 |
Authors | Studies |
---|---|
Deng, L; He, J; Huang, F; Lin, Q; Liu, K; Luo, L; Qiu, Q; Su, J; Zhang, W | 1 |
Jin, Y; Liu, F; Pan, L; Zhang, A; Zhi, Y | 1 |
Duan, J; Guo, S; Ma, X; Zhu, Z | 1 |
Cui, L; Cui, Z; Song, X; Xiang, L; Xu, C; Yang, Z; Zhu, W | 1 |
Cha, HJ; Chang, YC; Choi, EO; Choi, YH; Hwang, HJ; Kim, BW; Kim, GY; Kim, WJ; Kwon, DH; Leem, SH; Moon, SK; Yun, SJ | 1 |
Chang, R; Dou, L; Li, X; Li, Y; Wang, Y; Yang, X; Yue, Y; Zhang, W | 1 |
Duan, MH; Gao, Q; Su, X; Xu, DY; Yan, YL; Yang, Y; Zhang, WF | 1 |
7 other study(ies) available for schizandrin a and Disease Models, Animal
Article | Year |
---|---|
Schisandrin A ameliorates airway inflammation in model of asthma by attenuating Th2 response.
Topics: Animals; Asthma; Bronchoalveolar Lavage Fluid; Cyclooxygenase 2; Cytokines; Disease Models, Animal; Inflammation; Lignans; Mice; Mice, Inbred BALB C; NF-kappa B; Ovalbumin | 2023 |
Schisandrin A ameliorates MPTP-induced Parkinson's disease in a mouse model via regulation of brain autophagy.
Topics: Animals; Autophagy; Autophagy-Related Proteins; Behavior, Animal; Cyclooctanes; Disease Models, Animal; Dopaminergic Neurons; Humans; Inflammation Mediators; Lignans; Male; Mice; MPTP Poisoning; Neuroprotective Agents; PC12 Cells; Polycyclic Compounds; Rats; Substantia Nigra | 2019 |
The effect of deoxyschizandrin on chronic unpredictable mild stress-induced depression.
Topics: Animals; Antidepressive Agents; Chronic Disease; Cyclooctanes; Depression; Disease Models, Animal; Gene Expression Regulation; Hippocampus; Lignans; Male; Mice; Polycyclic Compounds; Stress, Psychological | 2021 |
Evidence of anti-inflammatory activity of Schizandrin A in animal models of acute inflammation.
Topics: Animals; Anti-Inflammatory Agents; Carrageenan; Cyclooctanes; Disease Models, Animal; Edema; Inflammation; Inflammation Mediators; Lignans; Male; Mice; NF-kappa B; Polycyclic Compounds; Signal Transduction; Toll-Like Receptor 4; Xylenes | 2020 |
Schisandrin A suppresses lipopolysaccharide-induced inflammation and oxidative stress in RAW 264.7 macrophages by suppressing the NF-κB, MAPKs and PI3K/Akt pathways and activating Nrf2/HO-1 signaling.
Topics: Animals; Cyclooctanes; Disease Models, Animal; Gene Expression Regulation, Enzymologic; Heme Oxygenase-1; Humans; Inflammation; Lignans; Lipopolysaccharides; Membrane Proteins; Mice; Mitogen-Activated Protein Kinase Kinases; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Polycyclic Compounds; Proto-Oncogene Proteins c-akt; RAW 264.7 Cells; Signal Transduction | 2018 |
Protective role of deoxyschizandrin and schisantherin A against myocardial ischemia-reperfusion injury in rats.
Topics: Animals; Apoptosis; Arrhythmias, Cardiac; Cardiotonic Agents; Caspase 3; Cyclooctanes; Cytoprotection; Dioxoles; Disease Models, Animal; Gene Expression Regulation; Hemodynamics; Hydrogen Peroxide; Lignans; Male; Malondialdehyde; Membrane Glycoproteins; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Myocytes, Cardiac; NADPH Oxidase 2; NADPH Oxidases; Polycyclic Compounds; Rats; Rats, Wistar; RNA, Messenger; Superoxide Dismutase | 2013 |
Deoxyschizandrin suppresses dss-induced ulcerative colitis in mice.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; CD4-Positive T-Lymphocytes; Cell Line; Colitis, Ulcerative; Cyclooctanes; Cytokines; Dextran Sulfate; Disease Models, Animal; Female; Gene Expression Regulation; Inflammation; Lignans; Mice; Mice, Inbred C57BL; Polycyclic Compounds | 2016 |